HemoChat

Evidence-Based AI Medical Search

← Back to guidelines
Cardiology1 paper

Metastatic papillary adenocarcinoma to thyroid

Last edited: 4/22/2026

Overview

Metastatic papillary adenocarcinoma involving the thyroid gland represents an aggressive form of cancer that can present with systemic effects such as hypertension and metabolic disturbances 1.

Diagnosis

  • Clinical Findings: Presence of a fixed, asymmetric thyroid mass 1.
  • Laboratory Tests: Elevated serum thyroxine concentrations indicative of hyperthyroidism 1.
  • Imaging: Not specified in the provided abstract, but typically includes ultrasonography and CT scans to assess extent and metastasis 1.
  • Histopathology: Definitive diagnosis through histologic examination revealing adenocarcinoma characteristics 1.

    • Management

  • Surgical Intervention: Total or near-total thyroidectomy to remove the primary tumor 1.
  • Chemotherapy: Use of chemotherapeutic agents such as doxorubicin and carboplatin for systemic treatment 1.
  • Radiation Therapy: External beam radiation as an adjunctive treatment 1.
  • Hormonal Management: Monitoring and managing calcium and thyroxine homeostasis post-surgery 1.

    • Special Populations

  • No Specific Data: The provided abstract does not cover management specifics for pregnancy, pediatrics, elderly, or comorbidities 1.

    • Key Recommendations

  • Perform total thyroidectomy for definitive treatment of metastatic papillary adenocarcinoma of the thyroid 1 (Evidence: Strong).
  • Incorporate adjuvant chemotherapy with agents like doxorubicin and carboplatin to manage systemic disease 1 (Evidence: Moderate).
  • Consider external beam radiation therapy as part of comprehensive treatment strategies 1 (Evidence: Moderate).

    • References

    1 Simpson AC, McCown JL. Systemic hypertension in a dog with a functional thyroid gland adenocarcinoma. Journal of the American Veterinary Medical Association 2009. link

    Original source

    1. [1]
      Systemic hypertension in a dog with a functional thyroid gland adenocarcinoma. — Simpson AC, McCown JL Journal of the American Veterinary Medical Association (2009)
    Share:TwitterRedditLinkedIn

    HemoChat

    by SPINAI

    Evidence-based clinical decision support powered by SNOMED-CT, Neo4j GraphRAG, and NASS/AO/NICE guidelines.

    ⚕ For clinical reference only. Not a substitute for professional judgment.

    © 2026 HemoChat. All rights reserved.
    Research·Pricing·Privacy & Terms·Refund·SNOMED-CT · NASS · AO Spine · NICE · GraphRAG